Practice
  • Home
  • News
  • Pin Points
  • Events
  • Programmes
  • Resources
  • About
REFINE YOUR SEARCH
FILTERS
CLEAR FILTERS
Tags
News » Improving diabetes prescribing in primary care

Improving diabetes prescribing in primary care

Pinnacle Incorporated | 24/03/2022

In New Zealand there are significant inequities in prescribing for diabetes and cardiovascular disease in primary care. Pinnacle is partnering with Waikato University, Hauraki and ProCare PHOs to explore the health system factors that may contribute to this.

This three-year project is funded by the Health Research Council, led by Associate Professor Lynne Chepulis and involving our own Dr Jo Scott Jones and Dr Rebekah Doran. The project is designed to:

  • evaluate and characterise the current rates of prescribing for diabetes (and to determine where inequities in prescribing exist), before
  • co-designing a primary-care led intervention to reduce prescribing inequity.

The first step in this process is for the research team to comprehensively review primary care data for patients with type 2 diabetes who have been enrolled with our practices since February 2021 (when the new diabetes agent empagliflozin was funded).

The goal is to compare prescribing practices of diabetes, cardiovascular and renal medications to relevant clinical guidelines. This will use and report on aggregated data only (at practice level), and individual GPs and clinical staff will not be critiqued or reported on.

What do we want from you?

The Pinnacle Digital Governance Group has approved this request in principle, and we are able to supply your practice data to the researchers. Nothing further is required on your part, unless you want to OPT OUT of this study.

If you DO NOT want your practice data to form part of this study, please notify us by emailing data@pinnacle.health.nz before 8 April 2022.

If you have any questions about the study please contact Associate Professor Lynne Chepulis or Dr Jo Scott Jones. 

 

Tags:
Cardiovascular Diabetes
YOU MAY ALSO BE INTERESTED IN
NEWS
Rural accelerated chest pain pathway receives recognition
Pinnacle Incorporated | 05/07/2018

Pinnacle has developed a rural chest pain assessment method that allows low-risk patients in rural communities to be safely assessed and managed by their general practice, rather than travelling significant distances to hospital - often needlessly.

Read more
Rural Cardiovascular
PIN POINTS
Pathlab: Changes to B-type Natriuretic Peptide (BNP) testing
Lakes | Waikato | Clinical | 17/12/2024

Pathlab has reported BNP levels using the Triage Method and using EDTA plasma as the preferred sample type. The current reference interval is 0-100 ng/L. From 23 December 2024, the current BNP method will be replaced by NT-proBNP. This method is more specific than BNP, as NT-proBNP has a longer half-life and is less influenced by factors like obesity or kidney function.

Read more
PROGRAMMES
ACC Deep venous thrombosis - DVT (POAC)
Taranaki | Cardiovascular | Under 18 | Over 18 | Over 65

Treatment of patients with suspected ACC related DVT with a Wells Score of >= 2 or a positive D-dimer.

View details
RESOURCE
Waikato Diabetes Manual
Published: 30/07/2024 | 1 file | Document

A guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.

View resource | Download files
Taranaki
47 Molesworth Street
New Plymouth 4310
+64 6 759 4364
Tairāwhiti
Level 1
295-299 Gladstone Road (entrance via Cobden Street)
Gisborne 4010
PO Box 1188
Gisborne 4040
06 863 2661
Lakes
Level 1
95 Te Heuheu Street
Taupō 3330
PO Box 1716
Taupō 3351
+64 7 376 0060
Waikato
Norris Ward McKinnon House
Level 3
711 Victoria Street
Hamilton 3204
PO Box 983
Hamilton 3240
+64 7 839 2888
Facebook @PinnacleIncorporated LinkedIn midlands-health-network
Copyright © 2025 Pinnacle Incorporated
Privacy policy Terms & conditions Practice update dashboard
Copyright © 2025 Pinnacle Incorporated
Privacy policy Terms & conditions Practice update dashboard